Stapleford Scientific Services Ltd, Madeline House, High Street, Babraham, Cambridge, CB24 3AG, UK.
Sagami Europe SAS, Château de Brugheas, 12C rue du Château, 03700, Brugheas, France.
Reprod Health. 2024 Sep 4;21(1):128. doi: 10.1186/s12978-024-01873-3.
Although natural rubber latex remains dominant as the primary manufacturing material for male condoms synthetic materials first introduced in the early 1990s address many of the limitations of latex including the risk of allergies. Polyurethane elastomers allow condoms to be made significantly thinner to provide greater sensitivity and encourage greater use of condoms for contraception and STI prophylaxis. The primary objective of this Study was to evaluate the breakage, slippage and acceptability of two ultra-thin polyurethane condoms against a thin control latex male condom, designated latex C, in a randomized, cross over, masked, non-inferiority study. The condom designated Polyurethane A was designed for markets where 52/53 mm wide latex condoms are preferred whereas the condom designated Polyurethane B was designed for markets where the smaller 49 mm wide latex condom is preferred.
The Study was designed to meet the requirements specified in ISO 29943-1: 2017 and FDA guidelines for clinical studies on synthetic condoms. It was conducted by two Essential Access Health centres, one in Northern California and the other in Southern California. Sexually active heterosexual couples (300) aged between 18 and 45 years were recruited to use three sets of five condoms in a block randomized order, recording breakage, slippage and acceptability after each use. A total of 252 couples contributed 2405 evaluable condom uses per protocol for the Condom A versus Latex C comparison (1193 Polyurethane A plus 1212 Latex C), and 247 couples provided 2335 evaluable condom uses per protocol for the Condom B versus Latex C comparison (1142 Polyurethane B plus 1193 Latex C). Only condoms used for vaginal intercourse were included in the analysis.
Although the total failure rates (breakage and slippage) for the polyurethane condoms were higher than for the control Latex C condom, all condoms performed extremely well with low failure rates compared to similar condom studies. Condom Polyurethane A met the noninferiority requirements specified in ISO 23409:2011 relative to Latex C, the control NR latex condom, in the full Study population. While condom Polyurethane B did not meet the noninferiority requirement for the full Study population, it did meet the noninferiority requirement when analysis was restricted to the intended population (men with penis lengths ≤ 170 mm). Trial registration The Study is registered with ClinicalTrials.gov, NCT04622306, Protocol Reference SAGCS 2, initial release date 11/02/2020.
尽管天然胶乳仍然是男用避孕套的主要制造材料,但 20 世纪 90 年代初推出的合成材料在很大程度上解决了胶乳的许多局限性,包括过敏风险。聚氨酯弹性体使避孕套可以做得更薄,从而提供更大的敏感度,并鼓励更多地使用避孕套进行避孕和性传播感染预防。本研究的主要目的是评估两种超薄聚氨酯避孕套在一项随机、交叉、盲法、非劣效性研究中与薄型对照乳胶男用避孕套(乳胶 C)相比的破裂、滑脱和可接受性。指定为聚氨酯 A 的避孕套专为喜欢 52/53 毫米宽乳胶避孕套的市场设计,而指定为聚氨酯 B 的避孕套专为喜欢较小的 49 毫米宽乳胶避孕套的市场设计。
该研究旨在满足 ISO 29943-1:2017 和 FDA 关于合成避孕套临床研究的要求。该研究由两个基本医疗保健中心进行,一个在加利福尼亚北部,另一个在加利福尼亚南部。招募了 300 名年龄在 18 至 45 岁之间的性活跃的异性恋夫妇,以块随机顺序使用三组五个避孕套,记录每次使用后的破裂、滑脱和可接受性。共有 252 对夫妇按照方案提供了 2405 次可评估的避孕套使用情况,用于比较避孕套 A 与乳胶 C(1193 个聚氨酯 A 和 1212 个乳胶 C),247 对夫妇按照方案提供了 2335 次可评估的避孕套使用情况,用于比较避孕套 B 与乳胶 C(1142 个聚氨酯 B 和 1193 个乳胶 C)。仅包括用于阴道性交的避孕套进行分析。
虽然聚氨酯避孕套的总失败率(破裂和滑脱)高于对照乳胶 C 避孕套,但所有避孕套的失败率都非常低,与类似的避孕套研究相比表现出色。避孕套聚氨酯 A 在全人群中符合 ISO 23409:2011 相对于乳胶 C(对照天然橡胶避孕套)的非劣效性要求。虽然避孕套聚氨酯 B 不符合全人群的非劣效性要求,但当分析仅限于目标人群(阴茎长度≤170 毫米的男性)时,它符合非劣效性要求。试验注册该研究在 ClinicalTrials.gov 注册,NCT04622306,方案参考 SAGCS 2,初始发布日期 2020 年 11 月 2 日。